Merrimack Pharmaceuticals Inc
MACKDelisted May 10, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001274792
Merrimack Pharmaceuticals Inc was delisted on May 10, 2024; its insiders filed their last Form 4 on Dec 28, 2023; 70 institutions reported holding it in 13F filings for Q1 2024, worth $137.1M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Merrimack Pharmaceuticals Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 62 | 63 | +1 |
| Shares | 8.01M | 8.47M | +464.6K (+5.8%) |
| Value | $98.5M | $104.4M | +$5.97M (+6.1%) |
New holders (7)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Centiva Capital, LP | 187,803 | $2.32M | 0.12% |
| Indaba Capital Management, L.P. | 136,802 | $1.69M | 0.50% |
| Group One Trading, L.P. | 4,528 | $55.8K | 0.00% |
| Deutsche Bank AG | 910 | $11.2K | 0.00% |
| Russell Investments Group, Ltd. | 864 | $10.7K | 0.00% |
| Comerica Bank | 500 | $6.17K | 0.00% |
| Nisa Investment Advisors, LLC | 15 | $185 | 0.00% |
Sold out (6)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Nantahala Capital Management, LLC | 111,148 | $1.37M |
| Marshall Wace, LLP | 87,037 | $1.07M |
| Boothbay Fund Management, LLC | 46,437 | $571.2K |
| Connor, Clark & Lunn Investment Management Ltd. | 14,405 | $177.2K |
| Millennium Management LLC | 10,749 | $132.2K |
| CWM, LLC | 275 | $3.00K |